Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

BridgeBio Pharma Stock Price, Quotes and Forecasts | NASDAQ:BBIO | Benzinga

Q: What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore BridgeBio Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BBIO.

Open	$38.85
Close	$38.57
Volume / Avg.	3.17M / 3.14M
Day Range	$38.12 - $39.16
52 Wk Range	21.62 - 39.54
Market Cap	$7.32B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	19.81%
Days to Cover	7.35

Recent News

Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Risk

Alnylam analysts highlight Amvuttra's strong launch positioning and limited tariff risk, with bullish ratings maintained despite early launch volatility.

Vandana Singh

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

BridgeBio's acoramidis wins Japan's approval for ATTR-CM. Phase 3 data show a 42% reduction in key heart-related events. AstraZeneca's Alexion to market it.

Vandana Singh

Top 4 Health Care Stocks You May Want To Dump In Q1

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$38.85
Close	$38.57
Volume / Avg.	3.17M / 3.14M
Day Range	$38.12 - $39.16
52 Wk Range	21.62 - 39.54
Market Cap	$7.32B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	19.81%
Days to Cover	7.35

About BridgeBio Pharma Inc

Sector

Health Care

Industry

Biotechnology

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and deliver...

Got Questions? Ask

How is the earnings season affecting BBIO?

What are analysts' targets for BBIO?

What is BBIO's gross margin?

What is BBIO's P/E ratio?

What is the Pivot resistance level for BBIO?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BridgeBio Pharma (BBIO) stock?

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Who are BridgeBio Pharma (BBIO) competitors?

Other companies in BridgeBio Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

BridgeBio Pharma has a consensus price target of $49.11.

What is the current price for BridgeBio Pharma (BBIO)?

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $38.57 last updated May 2, 2025 at 4:00 PM EDT.

Does BridgeBio Pharma (BBIO) pay a dividend?

There are no upcoming dividends for BridgeBio Pharma.

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

BridgeBio Pharma’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is BridgeBio Pharma (BBIO) going to split?

There is no upcoming split for BridgeBio Pharma.

What sector and industry does BridgeBio Pharma (BBIO) operate in?

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

BridgeBio Pharma Stock Price, Quotes and Forecasts

BridgeBio Pharma (BBIO) Forecast